Markets:

Overview

News

Currencies

International

Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

14.61 -1.13 (-7.18%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop ↗

May 07, 2021

Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81. The U.S. has the...

Via Benzinga

Topics Stocks

Stocks Reverse Course, Investors Look at Flip Side of Economic Data ↗

May 07, 2021

While a lackluster April jobs report initially sunk stocks this morning, the indexes are bouncing back as investors speculate that the disappointing data could mean the continuation of easy policies...

Via Talk Markets

Topics Economy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 07, 2021

Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is...

Via Benzinga

Why ChemoCentryx Stock Is Cratering Again Today ↗

May 07, 2021

Investors aren't optimistic after an FDA advisory committee vote for avacopan.

Via The Motley Fool

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide ↗

May 07, 2021

Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93. The U.S. has the...

Via Benzinga

Topics Stocks

56 Stocks Moving In Friday's Mid-Day Session ↗

May 07, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....

Via Benzinga

Why ChemoCentryx Shares Are Plunging Today ↗

May 07, 2021

ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Adds Only 266,000 Jobs In April ↗

May 07, 2021

Following the market opening Friday, the Dow traded up 0.40% to 34,686.06 while the NASDAQ rose 1.16% to 13,790.95. The S&P also rose, gaining 0.69% to 4,230.68. The U.S. has...

Via Benzinga

Topics Stocks

Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges ↗

May 07, 2021

Yesterday, the FDA’s Arthritis Advisory Committee panelists went through cloudy data while complaining about the design of the Phase 3 trial for ChemoCentryx Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021 ↗

May 07, 2021

Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from...

Via Benzinga

ChemoCentryx Stock Loses Half Its Value; Is This The Final Nail For Its Drug? ↗

May 07, 2021

A panel of experts was split Thursday on whether to recommend approval for ChemoCentryx's autoimmune disease drug — and CCXI stock plummeted Friday.

Via Investor's Business Daily

10 Biggest Price Target Changes For Friday ↗

May 07, 2021

Stifel boosted Wayfair Inc. (NYSE: W) price target from $200 to $280. Wayfair shares rose 1.7% to $290.91 in pre-market trading. RBC Capital raised ViacomCBS Inc. (NASDAQ: VIAC...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 07, 2021

Gainers Assertio Holdings (NASDAQ:ASRT) shares moved upwards by 32.42% to $0.66 during Friday's pre-market session. The company's market cap stands at $114.5...

Via Benzinga

Adcomm Split On FDA Approval For ChemoCentryx's Vasculitis Candidate ↗

May 07, 2021

The FDA’s Arthritis Advisory Committee voted 10 for and 8 against the approval of ChemoCentryx Inc’s (NASDAQ: CCXI) investigational drug...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 05, 2021

Gainers Chiasma (NASDAQ:CHMA) stock moved upwards by 39.04% to $3.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $228.4...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 04, 2021

Gainers Obalon Therapeutics (NASDAQ:OBLN)...

Via Benzinga

Why ChemoCentryx Stock Crashed Today ↗

May 04, 2021

The FDA's briefing documents for an advisory committee don't appear to bode well for avacopan's chances of approval.

Via The Motley Fool

Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today ↗

May 04, 2021

Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc. (NASDAQ: STIM) and BioLineRx Ltd. (NASDAQ: BLRX) are among the biggest health care...

Via Benzinga

Dow Stares at Triple-Digit Landslide While Tech Takes a Hit ↗

May 04, 2021

The Nasdaq is down more than 2% this afternoon as FAANG stocks weigh.

Via Talk Markets

Topics Stocks

ChemoCentryx Stock Plunges As FDA Briefing Document Casts Doubt On Vasculitis Candidate Avacopan's Data ↗

May 04, 2021

ChemoCentryx Inc (NASDAQ: CCXI) shares plunged after an FDA briefing document indicates the agency has “several areas of concerns” with its vasculitis...

Via Benzinga

Why ChemoCentryx's Stock Is Plunging Today ↗

May 04, 2021

ChemoCentryx, Inc. (NASDAQ: CCXI) shares are trading lower after FDA briefing documents for avacopan identified areas of concern, which raised "uncertainties about the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 04, 2021

Gainers Cocrystal Pharma (NASDAQ:COCP) stock rose 143.41% to $3.02 during Tuesday's regular session. Trading volume for Cocrystal Pharma's stock is 378.0 million...

Via Benzinga

44 Stocks Moving In Tuesday's Mid-Day Session ↗

May 04, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Pfizer Raises FY21 Outlook ↗

May 04, 2021

Following the market opening Tuesday, the Dow traded down 0.58% to 33,914.95 while the NASDAQ fell 1.94% to 13,625.24. The S&P also fell, dropping 0.95% to 4,152.79. The U.S....

Via Benzinga

Topics Stocks

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.